# One Health Group plc: Sustaining Profits and Transforming Capacity, analyst view

- Link: https://www.directorstalkinterviews.com/one-health-group-plc-sustaining-profits-and-transforming-capacity-analyst-view/4121165929
- Published: 2024-07-25T07:00:00+01:00
- Author: Anthony Fox

**[One Health Group plc](https://www.directorstalkinterviews.com/company/one-health-group-plc/ohgr.l)**(
LON:OHGR) is an independent provider of elective NHS-funded medical procedures, 
achieving significant milestones in FY 2024. With a record of 13.3k new referrals,
the Group’s revenue surged by 13% to £23.5m, surpassing the forecasted £21.5m. The
Group has been pivotal in meeting the escalating demand for additional healthcare
capacity, maintaining excellent service quality. The following is an in-depth analysis
of OHGR’s performance, growth strategy, and future prospects based on the research
conducted by Oberon Capital, with insights from Analyst Emma Ulker.

#### Financial Performance

FY 2024 witnessed a 14% increase in turnover, reaching £23.3m, primarily driven 
by the rise in surgical procedures to 6,169 from 5,790 in the previous year. The
Group’s operating profit rose by 6% to £1.6m, with a stable gross margin of 17%.
However, adjusted earnings per share (EPS) dipped to 10.2p from 11.3p due to an 
increased corporation tax rate and higher share issuance. OHGR’s year-end cash position
was robust at £4.7m, comfortably above the £4.1m forecast, enabling continued investment
in growth and supporting the Group’s progressive dividend policy.

#### Strategic Growth Initiatives

The Group’s growth strategy remains focused on responding to rising demand and expanding
capacity. OHGR has firm plans to invest cash flow generated by its underlying business
into its first owned Surgical Hub. This hub is projected to have a transformational
impact on profitability from its inception, with near-term margin accretion expected
from FY 2026.

Emma Ulker highlights, “The growth strategy hinges on continuing to respond to demand
coupled with near-term capacity expansion. This is set to be executed by continuing
to grow and fill spare third-party capacity and investing in owned Surgical Hubs,
which will significantly enhance Group profitability.”

#### Positive Growth Outlook

OHGR continues to attract new surgical consultants, increasing its roster by five
to 63, with a further 18 potential consultants in the pipeline. The Group has benefited
from additional revenue streams through local NHS Trust waiting list transfers, 
aiding the NHS in its elective recovery plan post-COVID-19. The new 5-year contracts
with the two largest commissioners from April 2024 further solidify OHGR’s market
position, replacing annual renewals and providing better visibility on service and
sales.

#### Transformational Prospects of Surgical Hubs

The first Surgical Hub is expected to cost approximately £5.7m to build and is capable
of generating a gross margin of around 30%, compared to the current 17% margin from
third-party facilities. This hub will enhance Group operating margin by employing
theatre support staff and nurses, significantly boosting profitability from its 
launch. The hub will initially focus on high-tariff orthopaedic and spinal procedures,
with full capacity anticipated to be reached within the first months of operation.

Ulker notes, “The first surgical hub will deliver additional ‘owned’ operating capacity,
reducing bottlenecks and enabling OHGR to treat a higher volume of patients at a
higher margin.”

#### Forecasts and Valuation

Oberon Capital’s forecasts for FY24-28 indicate a 14% revenue compound annual growth
rate (CAGR) and a 24% EBITDA CAGR, illustrating an accelerated profitability profile
that supports OHGR’s progressive dividend policy. The valuation of OHGR stands at
£26m, equivalent to 249p per share, based on a combination of discounted cash flow(
DCF) and peer multiples.

Table 1: Summary of Financial Forecasts

| **Year End** | **2023A** | **2024A** | **2025E** | **2026E** | **2027E** | **2028E** | 
| Revenue (£’000) | 20,502 | 23,306 | 25,830 | 29,926 | 35,950 | 38,400 | 
| EBITDA (£’000) | 1,532 | 1,624 | 1,914 | 2,423 | 3,534 | 3,936 | 
| EPS (p) | 11.3 | 10.2 | 13.2 | 17.2 | 25.3 | 28.4 | 
| Dividend per Share (p) | 6.0 | 6.1 | 6.2 | 6.3 | 6.4 | 6.5 |

#### Final Thoughts

One Health Group plc has demonstrated resilience and strategic foresight in sustaining
profits and generating cash amidst rising demand for healthcare services. With robust
financial performance, strategic investments in owned capacity, and a strong growth
outlook, OHGR is well-positioned to continue delivering high-quality medical procedures
and expanding its market presence. As highlighted by Emma Ulker, “OHGR’s investment
in Surgical Hubs is set to transform its profitability and capacity, making it a
crucial player in the independent healthcare sector.”

Share on:
